Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study [Erratum]
Minakata Y, Motegi T, Ueki J, et al. Int J Chron Obstruct Pulmon Dis. 2019;14:1789–1801.During the publication process there was an operator error where the supplementary materials, mentioned on pages 1790 and 1793, were omitted from the manuscript. Please see the supplementary materials i...
Main Authors: | Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | International Journal of COPD |
Online Access: | https://www.dovepress.com/erratum-effect-of-tiotropiumolodaterol-on-sedentary-and-active-peer-reviewed-article-COPD |
Similar Items
-
Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study
by: Minakata Y, et al.
Published: (2019-08-01) -
Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity
by: Ichinose M, et al.
Published: (2018-05-01) -
Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis
by: Halpin DMG, et al.
Published: (2015-02-01) -
Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
by: LaForce C, et al.
Published: (2018-06-01) -
Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)